ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-04456
製品名称
PKC nu Protein, Human, Recombinant (GST)
タンパク質名
PKC nu
Species
Human
HOST
Baculovirus Insect Cells
50μg: -
お問い合わせ

Overview

Synonyms PRKCN, nPKC-NU, PKC-NU, PKD3, EPK2, protein kinase D3
Characteristics Kinase activity untested
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity ? 80 % as determined by SDS-PAGE
Description Serine/threonine-protein kinase D3, also known as Protein kinase C nu type, Protein kinase EPK2, PRKD3, EPK2 and PRKCN, is a cytoplasm and membrane protein that belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family and PKD subfamily. PRKD3 / PRKCN contains one PH domain, two phorbol-ester/DAG-type zinc fingers and one protein kinase domain. Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. They also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. PRKD3 / PRKCN converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. It is involved in resistance to oxidative stress. PRKD3 / PRKCN is activated by DAG and phorbol esters. Phorbol-ester/DAG-type domains 1 and 2 bind both DAG and phorbol ester with high affinity and mediate translocation to the cell membrane. Autophosphorylation of Ser-735 and phosphorylation of Ser-731 by PKC relieves auto-inhibition by the PH domain. PRKD3 / PRKCN can be activated rapidly by the agonists of G protein-coupled receptors. It resides in both cytoplasm and nucleus, and its nuclear accumulation is found to be dramatically enhanced in response to its activation. PRKD3 / PRKCN can also be activated after B-cell antigen receptor (BCR) engagement, which requires intact phospholipase C gamma and the involvement of other PKC family members.
Reference Mayne M, et al., 2000, J. Immunol.?164?(12): 6538-42.Ali A, et al., 2002, Chem. Rev.?101?(8): 2527-40.,HAyashi A, et al., 1999, Biochim Biophys Acta?1450?(1): 99-106.,Schultz SJ, et al.,1994, Cell Growth Differ.?4?(10): 821-30.
URL https://www.targetmol.com/recombinant-protein/pkc_nu_protein_human_recombinant_gst_tag_

お問い合わせリスト(-)

お問い合わせフォーム